RPL7L1P13

Across TCGA pan-cancer cohorts, RPL7L1P13 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RPL7L1P13 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RPL7L1P13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL7L1P13 expression acts as an unfavorable survival marker, although some lineages such as KIRC and KIRP show a favorable association.

CHOL, DLBC, and ACC are the cancer types where RPL7L1P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.089	0.718	<.001	90	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	42	view →
ACC	DFS	Tertile	III,IV	0.010	0.364	<.001	39	view →
KIRC	DFS	Tertile	All	0.838	0.540	.001	24	view →
KICH	DFS	Tertile	II,III,IV	0.241	0.806	.002	21	view →
BRCA	DFS	Tertile	II,III,IV	0.826	0.896	.033	18	view →
LUAD	OS	Tertile	III,IV	0.454	0.721	.008	18	view →
KIRP	DFS	Median	IV	0.594	0.039	.005	17	view →
SKCM	OS	Tertile	IV	0.226	0.613	.034	9	view →
STAD	OS	Tertile	All	0.365	0.576	.015	9	view →
UCS	OS	Tertile	All	0.616	0.250	.024	6	view →
BLCA	DFS	Tertile	IV	0.791	0.291	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RPL7L1P13–CHOL (OS)

Open the CHOL breakdown →